Customize
Quick Links
Past Events

Accreditation/
Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC and Pharmacy Times Continuing Education. Physicians’ Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 22.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 22.0 Contact Hours.


Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for a maximum of 22.0 contact hours (0.22 CEUs).

Acknowledgment of Commercial Support

This activity is supported by educational grants from Ariad Pharmaceuticals, Inc., AstraZeneca, Celgene Corporation, Clovis Oncology, Eisai, Exelixis, Inc., Genomic Health, Inc., Incyte, Lilly, Medivation, Inc., Merck, NantHealth, Inc., Novartis Pharmaceuticals Corporation, Novocure Inc., Pfizer, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Taiho Oncology, Inc., Takeda Oncology, Tesaro, and Teva Pharmaceuticals.

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.



The Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® is wholly owned and operated by PER Events, LLC, an affiliate of Physicians' Education Resource®.
About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

34th Annual CFS™ Chemotherapy Foundation Satellite Symposium®

34th Annual CFS™ Chemotherapy Foundation Satellite Symposium®


Thursday, November 10, 2016
10:30 AM - 12:00 PM
CME-Certified Concurrent Symposium - Live Taping: The Expanding Role of PARP Inhibitors in the Treatment of Ovarian Cancers – Current Strategies and Future Direction
 
New York Marriott Marquis
1535 Broadway
New York, NY 10036
Room: Julliard Complex (5th Floor)

 

Registration

Registration is complimentary, but seating is limited. Please register here.
 
 
Overview

This edition of Medical Crossfire®, filmed in conjunction with the 34th Annual CFS Chemotherapy Foundation Symposium®, has been designed to provide a dynamic discussion of the expanding role of poly ADP-ribose polymerase (PARP) inhibitors in the care of patients with ovarian cancer. With one PARP inhibitor already approved for ovarian cancer (in patients with BRCA-mutated disease) by the Food and Drug Administration and several others in phase III testing in various indications, the time is, now, for clinicians to get up-to-date on the rationale for the use of PARP inhibitors in this lethal disease, as well as the established and emerging clinical data supporting their use.
 
Our activity chair, Maurie Markman, MD, and our expert faculty will each present brief overviews of key topics related to PARP inhibitors in ovarian cancer, including their rationale, resistance mechanisms to PARP inhibition, their use in different treatment strategies, and the role of genetic testing to identify those patients to be treated with these agents. Each presentation will be followed by an engaging panel discussion and Q&A session led by Dr. Markman.  

Target Audience

This educational activity is directed toward all attendees of the 34th Annual CFS Chemotherapy Foundation Symposium®, including physicians, nurse practitioners, nurses, and physician assistants with an interest in treating patients with ovarian cancer. Pharmacists, researchers, and other health care providers interested in the treatment of ovarian cancer are also be invited to attend.

Educational Objectives

Upon completion of this activity, participants will be better prepared to:
  • Describe the rationale for the application of PARP inhibitors in ovarian cancer
  • Outline the resistance mechanisms to PARP inhibitors in ovarian cancer
  • Discuss the evolving treatment strategies for PARP inhibition in the treatment of ovarian cancer, including the role in monotherapy, combination therapy, and maintenance therapy
  • Assess the role of genetic testing and biomarkers for the identification of patients with ovarian cancer to be treated with PARP inhibition, including those with BRCA-mutated disease
 
Activity Chair



Maurie Markman, MD
Medical Oncologist
President, Medicine and Science
Cancer Treatment Centers of America
 

Faculty



Michael J. Birrer, MD, PhD
Professor, Harvard Medical School
Director, Gynecologic Medical Oncology
Massachusetts General Hospital Leader, DF/HCC Gynecologic Cancers Program


Michael A. Bookman, MD
Director, Gynecologic Oncology Research
US Oncology Research and Arizona Oncology


Mark E. Robson, MD
Attending Physician, Clinical Genetics and Breast Medicine Services
Clinic Director, Clinical Genetics Service
Memorial Sloan Kettering Cancer Center UC College of Medicine


Accreditation/Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Aknowledgement of Commercial Support

This activity is supported by an educational grant from Clovis Oncology Inc., Foundation Medicine, and Tesaro Inc.

 

Photos from the 34th Annual CFS™ Chemotherapy Foundation Satellite Symposium®













Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
      1
2345678
9101112131415
16171819202122
23242526272829
30
Filter By